193 related articles for article (PubMed ID: 24350318)
1. Current practices in the management of diabetic nephropathy.
Chan G; Tang SC
J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
[TBL] [Abstract][Full Text] [Related]
2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
3. The role of angiotensin receptor blockers in diabetic nephropathy.
Sharma AM; Weir MR
Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
[TBL] [Abstract][Full Text] [Related]
4. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
5. Diabetic nephropathy.
Ritz E
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
[TBL] [Abstract][Full Text] [Related]
6. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL; Odum LE; Whaley-Connell AT
Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
8. Diabetic nephropathy -- a multifaceted target of new therapies.
Choudhury D; Tuncel M; Levi M
Discov Med; 2010 Nov; 10(54):406-15. PubMed ID: 21122472
[TBL] [Abstract][Full Text] [Related]
9. Pancreas transplantation for the prevention of diabetic nephropathy.
Stegall MD; Larson TS; Kudva YC; Grande JP; Nyberg SL; Prieto M; Velosa JA; Rizza RA
Mayo Clin Proc; 2000 Jan; 75(1):49-56. PubMed ID: 10630757
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in the management of diabetic nephropathy.
Waanders F; Visser FW; Gans RO
Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
[TBL] [Abstract][Full Text] [Related]
11. Progression of chronic renal disease and diabetic nephropathy: a review of clinical studies and current therapy.
Marinides GN
J Med; 1993; 24(4-5):266-88. PubMed ID: 8258740
[TBL] [Abstract][Full Text] [Related]
12. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
de la Sierra A; Salazar J
Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
[TBL] [Abstract][Full Text] [Related]
13. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
14. Screening and management of patients with early chronic kidney disease.
Rossert J; Fouqueray B
Acta Diabetol; 2004 Mar; 41 Suppl 1():S6-12. PubMed ID: 15103542
[TBL] [Abstract][Full Text] [Related]
15. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
17. [Current issues in the diagnosis and therapy of diabetic nephropathy].
de Châtel R; Mogyorósi A; Ziyadeh FN
Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
Schnack C; Schernthaner G
Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
[TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy.
Ibrahim HA; Vora JP
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Jul; 13(2):239-64. PubMed ID: 10761865
[TBL] [Abstract][Full Text] [Related]
20. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
